David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.52B |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$620M |
| 3 |
Pfizer
PFE
|
+$449M |
| 4 |
American International
AIG
|
+$403M |
| 5 |
Walmart Inc
WMT
|
+$392M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.87% |
| 2 | Financials | 8.04% |
| 3 | Healthcare | 7.54% |
| 4 | Consumer Discretionary | 7.27% |
| 5 | Energy | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
CALL
Amazon
AMZN
$2.79T
| $39.4M | 0.07% |
+2,840,600
| New | +$37.8M |
|
|
BRCM
277
DELISTED
BROADCOM CORP CL-A
BRCM
| $39.4M | 0.07% |
+1,167,231
| New | +$40.6M |
|
278
Verizon
VZ
$205B
| $39.4M | 0.07% |
+781,806
| New | +$39.9M |
|
|
MRSH
279
Marsh
MRSH
$91.6B
| $39.2M | 0.07% |
+982,243
| New | +$38.4M |
|
|
WBA
280
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $39.1M | 0.07% |
+884,400
| New | +$43.1M |
|
|
PXD
281
PUT
DELISTED
Pioneer Natural Resource Co.
PXD
| $39.1M | 0.07% |
+270,000
| New | +$36M |
|
282
PUT
Chipotle Mexican Grill
CMG
$46.7B
| $39.1M | 0.07% |
+5,360,000
| New | +$38.5M |
|
283
NVR
NVR
$16.9B
| $39M | 0.07% |
+42,322
| New | +$42.1M |
|
284
Bank of America
BAC
$431B
| $39M | 0.07% |
+3,032,078
| New | +$38.7M |
|
285
Crown Castle
CCI
$32.1B
| $38.9M | 0.07% |
+537,337
| New | +$39.4M |
|
286
iShares MSCI Emerging Markets ETF
EEM
$30.7B
| $38.8M | 0.07% |
+1,005,557
| New | +$41.7M |
|
287
Pentair
PNR
$10.3B
| $38.8M | 0.07% |
+1,000,590
| New | +$37.4M |
|
288
NetApp
NTAP
$37.7B
| $38.5M | 0.07% |
+1,019,435
| New | +$36.9M |
|
289
PUT
CF Industries
CF
$19.6B
| $38.3M | 0.07% |
+1,115,500
| New | +$41.6M |
|
290
Teva Pharmaceuticals
TEVA
$43.5B
| $38.1M | 0.07% |
+971,861
| New | +$37.8M |
|
|
ITC
291
DELISTED
ITC HOLDINGS CORP
ITC
| $38M | 0.07% |
+1,248,057
| New | +$37.2M |
|
292
Zebra Technologies
ZBRA
$17.4B
| $37.8M | 0.07% |
+870,548
| New | +$39.6M |
|
293
PUT
McDonald's
MCD
$192B
| $37.7M | 0.07% |
+380,500
| New | +$38.1M |
|
294
SBA Communications
SBAC
$19.4B
| $37.4M | 0.07% |
+504,189
| New | +$38.4M |
|
295
CALL
Johnson & Johnson
JNJ
$651B
| $37.1M | 0.07% |
+432,400
| New | +$36.7M |
|
|
TIBX
296
DELISTED
TIBCO SOFTWARE INC
TIBX
| $36.9M | 0.07% |
+1,726,227
| New | +$35.4M |
|
297
CALL
Gilead Sciences
GILD
$181B
| $36.9M | 0.07% |
+719,700
| New | +$37.5M |
|
298
CALL
DuPont de Nemours
DD
$18.7B
| $36.6M | 0.07% |
+449,335
| New | +$37.9M |
|
|
EXAS
299
DELISTED
Exact Sciences
EXAS
| $36.4M | 0.07% |
+2,616,002
| New | +$28.4M |
|
300
Thermo Fisher Scientific
TMO
$233B
| $36.4M | 0.07% |
+429,574
| New | +$35.8M |
|
Similar funds
David Shaw's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for David Shaw, which disclosed 3,939 positions worth $53.2B. Its ten largest holdings account for 15% of the portfolio.
Its largest position is Apple: 99,088,976 shares worth $1.4B.
By sector, the portfolio is most concentrated in Technology at 9.9% of assets, followed by Financials and Healthcare.
- David Shaw's largest Q2 2013 buy was Apple: 99,088,976 shares worth $1.4B.
- David Shaw's ten largest holdings make up 15% of its $53.2B portfolio in Q2 2013.
- David Shaw disclosed 3,939 positions in Q2 2013, its first 13F filing on record.
Based on D.E. Shaw & Co's 13F filing for Q2 2013, filed 14 Aug 2013.